Skip To Main Content
Michal Ruprecht on Muck Rack

Michal Ruprecht

(He/Him)
  • Pulitzer Center Grantee and Stanford Global Health Media Fellow, NPR
Atlanta
As seen in: NPR, CNN, CNN en Español, MSN, Yahoo Singapore, ABC News, Aol, Flipboard, Yahoo Noticias, Yahoo Sports, Yahoo and
Health reporter @cnn MD student @waynemedicine past @npr @abc #goblue 📧mrup.01@proton.me 📞+1 (707) 412-8684 Signal: mrup.01

Get in touch with Michal

Contact Michal, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Michal Ruprecht’s Journalist Portfolio

Journalism Portfolio

Journalism Portfolio

View article →

Articles

The drug lenacapavir is a mighty weapon against HIV. Its rollout gets mixed reviews

|
By Michal Ruprecht
| Texas Public Radio (San Antonio, TX) Verified
Kalisizo, Uganda — Along the deeply rutted red dirt roads of central Uganda's Lake Victoria coast, there is little for miles beyond banana groves and bustling markets. The landscape is unassuming — and very dusty. Yet few places have done more to shape HIV care. Irene knows this well. For the past three years, the soft-spoken 22-year-old, who is HIV-negative, has been a participant in one of the most influential HIV clinical trials.
Open in Who Shared View Duplicates (70) Issue with article?

The drug lenacapavir is a mighty weapon against HIV. Its rollout gets mixed reviews

|
By Michal Ruprecht
| WUOM-FM (Ann Arbor, MI) Verified
Kalisizo, Uganda — Along the deeply rutted red dirt roads of central Uganda's Lake Victoria coast, there is little for miles beyond banana groves and bustling markets. The landscape is unassuming — and very dusty. Yet few places have done more to shape HIV care. Irene knows this well. For the past three years, the soft-spoken 22-year-old, who is HIV-negative, has been a participant in one of the most influential HIV clinical trials.
Open in Who Shared Issue with article?

The drug lenacapavir is a mighty weapon against HIV. Its rollout gets mixed reviews

|
By Michal Ruprecht
| KSFR-FM (Santa Fe, NM) Verified
Kalisizo, Uganda — Along the deeply rutted red dirt roads of central Uganda's Lake Victoria coast, there is little for miles beyond banana groves and bustling markets. The landscape is unassuming — and very dusty. Yet few places have done more to shape HIV care. Irene knows this well. For the past three years, the soft-spoken 22-year-old, who is HIV-negative, has been a participant in one of the most influential HIV clinical trials.
Open in Who Shared Issue with article?
See all 3,193 licensed articles (3,226 Total)